Abdominal Binder and Steps Trial
ABS
Abdominal Binder and Steps (ABS): A Way to Improve Ambulation Post-Laparotomy in Benign GYN Surgery
1 other identifier
interventional
85
1 country
1
Brief Summary
Large lower abdominal incisions are still used in many types of common gynecologic surgeries. Patients may experience pain and restrictions to ambulation because of this, which can make healing after surgery harder and more complicated. Abdominal binders, through their added abdominal support, may provide a low cost intervention to help people heal. The study team aims to investigate the effects of abdominal binders on walking in the post- gynecologic surgery period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 1, 2020
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedStudy Start
First participant enrolled
June 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedAugust 15, 2024
August 1, 2024
2.9 years
June 1, 2020
August 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Daily step counts
Daily step counts taken via electronic step counter over the course of two weeks.
Two weeks (until post-operative appointment when step counter is returned)
Secondary Outcomes (4)
Time to Ambulation
Within 24 hours (post-operative day one)
Narcotic utilization
24-48 hours post-operatively (the typical time from surgery to discharge)
Visual analogue pain scale
24-48 hours post-operatively (the typical time from surgery to discharge)
Number of participants who thinks there was a benefit
Two weeks (at time of post-operative visit)
Study Arms (2)
Abdominal Binder
EXPERIMENTALDuring this time they will wear a step counter and track their steps. This step counter will be returned at the time of their two week visit.
Control
OTHERThis group of patients will not wear abdominal binders, but during this time they will wear a step counter and track their steps. This step counter will be returned at the time of their two week visit.
Interventions
Eligibility Criteria
You may qualify if:
- English-speaking
- Female
- Patients undergoing benign hysterectomy or myomectomy via low-transverse laparotomy.
You may not qualify if:
- ASA classification of three or higher
- Malignancy
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mount Sinai Hospital
New York, New York, 10128, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles Ascher-Walsh, MD
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Study Record Dates
First Submitted
June 1, 2020
First Posted
June 4, 2020
Study Start
June 28, 2020
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
August 15, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose. To achieve aims in the approved proposal. Email to the primary investigator with IRB-approved proposal.
All of the individual participant data collected during the trial, after deidentification.